NO20006380L - Amidino- og guanidino-azetidinon-tryptaseinhibitorer - Google Patents

Amidino- og guanidino-azetidinon-tryptaseinhibitorer

Info

Publication number
NO20006380L
NO20006380L NO20006380A NO20006380A NO20006380L NO 20006380 L NO20006380 L NO 20006380L NO 20006380 A NO20006380 A NO 20006380A NO 20006380 A NO20006380 A NO 20006380A NO 20006380 L NO20006380 L NO 20006380L
Authority
NO
Norway
Prior art keywords
azetidinone
guanidino
amidino
tryptase inhibitors
tryptase
Prior art date
Application number
NO20006380A
Other languages
English (en)
Other versions
NO20006380D0 (no
Inventor
Gregory S Bisacchi
William A Slusarchyk
Uwe Treuner
James C Sutton
Robert Zahler
Steven Seiler
David R Kronenthal
Michael E Randazzo
Zhongmin Xu
Zhongping Shi
Mark D Schwinden
Original Assignee
Bristol Myers Squibb Co
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Bristol Myers Squibb Co filed Critical Bristol Myers Squibb Co
Publication of NO20006380D0 publication Critical patent/NO20006380D0/no
Publication of NO20006380L publication Critical patent/NO20006380L/no

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D403/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00
    • C07D403/02—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00 containing two hetero rings
    • C07D403/12—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00 containing two hetero rings linked by a chain containing hetero atoms as chain links
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00—Drugs for disorders of the respiratory system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00—Drugs for disorders of the respiratory system
    • A61P11/02—Nasal agents, e.g. decongestants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00—Drugs for disorders of the respiratory system
    • A61P11/06—Antiasthmatics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A61P37/08—Antiallergic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P7/00—Drugs for disorders of the blood or the extracellular fluid
    • A61P7/02—Antithrombotic agents; Anticoagulants; Platelet aggregation inhibitors
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D205/00—Heterocyclic compounds containing four-membered rings with one nitrogen atom as the only ring hetero atom
    • C07D205/02—Heterocyclic compounds containing four-membered rings with one nitrogen atom as the only ring hetero atom not condensed with other rings
    • C07D205/06—Heterocyclic compounds containing four-membered rings with one nitrogen atom as the only ring hetero atom not condensed with other rings having one double bond between ring members or between a ring member and a non-ring member
    • C07D205/08—Heterocyclic compounds containing four-membered rings with one nitrogen atom as the only ring hetero atom not condensed with other rings having one double bond between ring members or between a ring member and a non-ring member with one oxygen atom directly attached in position 2, e.g. beta-lactams

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Veterinary Medicine (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Public Health (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Pulmonology (AREA)
  • Immunology (AREA)
  • Cardiology (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Diabetes (AREA)
  • Hematology (AREA)
  • Pain & Pain Management (AREA)
  • Rheumatology (AREA)
  • Otolaryngology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Plural Heterocyclic Compounds (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
NO20006380A 1998-06-25 2000-12-14 Amidino- og guanidino-azetidinon-tryptaseinhibitorer NO20006380L (no)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US9063698P 1998-06-25 1998-06-25
PCT/US1999/013811 WO1999067215A1 (en) 1998-06-25 1999-06-18 Amidino and guanidino azetidinone tryptase inhibitors

Publications (2)

Publication Number Publication Date
NO20006380D0 NO20006380D0 (no) 2000-12-14
NO20006380L true NO20006380L (no) 2000-12-14

Family

ID=22223632

Family Applications (1)

Application Number Title Priority Date Filing Date
NO20006380A NO20006380L (no) 1998-06-25 2000-12-14 Amidino- og guanidino-azetidinon-tryptaseinhibitorer

Country Status (24)

Country Link
EP (1) EP1089973B1 (no)
JP (1) JP2002518478A (no)
KR (1) KR20010053173A (no)
CN (1) CN1202081C (no)
AR (1) AR018945A1 (no)
AT (1) ATE309211T1 (no)
AU (1) AU752320B2 (no)
BR (1) BR9911373A (no)
CA (1) CA2336003A1 (no)
DE (1) DE69928257T2 (no)
ES (1) ES2249017T3 (no)
HU (1) HUP0104308A3 (no)
ID (1) ID27137A (no)
IL (1) IL140414A0 (no)
NO (1) NO20006380L (no)
NZ (1) NZ507627A (no)
PE (1) PE20000729A1 (no)
PL (1) PL345067A1 (no)
RU (1) RU2211832C2 (no)
TR (1) TR200003859T2 (no)
TW (1) TW548270B (no)
UY (1) UY25580A1 (no)
WO (1) WO1999067215A1 (no)
ZA (1) ZA200006028B (no)

Families Citing this family (13)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2005063704A1 (ja) 2003-12-25 2005-07-14 Ono Pharmaceutical Co., Ltd. アゼチジン環化合物およびその医薬
WO2006062110A1 (ja) * 2004-12-06 2006-06-15 Banyu Pharmaceutical Co., Ltd. ピペラジン誘導体
JP5846527B2 (ja) * 2010-02-17 2016-01-20 国立大学法人京都大学 ＴＧＦ−βシグナル伝達阻害剤
AR095569A1 (es) * 2013-03-20 2015-10-28 Hoffmann La Roche Derivados de urea
EP2989080A1 (en) 2013-04-22 2016-03-02 Reuter Chemische Apparatebau KG Process for preparing enantiomerically enriched 3-hydroxymethylpiperidine
EP3036219A4 (en) * 2013-06-04 2017-08-23 Temple University Of The Commonwealth System Of Higher Education Novel beta lactams as modulators of glutamate uptake and methods for use thereof
EP4309653A1 (en) 2014-02-07 2024-01-24 Exithera Pharmaceuticals Inc. Therapeutic compounds and compositions
CA3089970A1 (en) 2018-02-07 2019-08-15 eXIthera Pharmaceuticals Inc. Therapeutic compounds and compositions
EP3778588A4 (en) * 2018-03-30 2021-04-28 Shanghai Meiyue Biotech Development Co., Ltd. QUATERNARY LACTAM COMPOUND AND ITS PHARMACEUTICAL USE
CN109988098A (zh) * 2019-05-23 2019-07-09 常州工程职业技术学院 一种(r)-n-叔丁氧羰基-3-羟甲基哌啶的合成方法
CN114040908A (zh) * 2019-06-25 2022-02-11 广东东阳光药业有限公司 一种凝血因子XIa抑制剂的晶型及其制备方法
CA3160619A1 (en) 2019-11-08 2021-05-14 Coave Therapeutics Modified adeno-associated virus vectors and delivery thereof into the central nervous system
CA3196597A1 (en) * 2020-11-06 2022-05-12 Gaelle Lefevre Lactam-modified adeno-associated virus vectors

Family Cites Families (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5037819A (en) * 1990-06-04 1991-08-06 Bristol-Myers Squibb Company Azetidin-2-one derivatives as serine protease inhibitors
US5250677A (en) * 1990-06-04 1993-10-05 Bristol-Myers Squibb Company Azetidin-2-one derivatives as serine protease inhibitors
US5110812A (en) * 1990-06-04 1992-05-05 Bristol-Myers Squibb Co. Azetidin-2-one derivatives as serine protease inhibitors
US5175283A (en) * 1990-06-04 1992-12-29 Bristol-Myers Squibb Company Azetidin-2-one derivatives as serine protease inhibitors
US5747485A (en) * 1995-04-13 1998-05-05 Merck & Co., Inc. Substituted azetidiones as anti-inflammatory and antidegenerative agents
CA2266639A1 (en) * 1996-09-23 1998-03-26 Rajeshwar Singh 3,4-disubstituted azetidin-2-one derivatives useful as cysteine proteinase regulators

Also Published As

Publication number Publication date
AU4695099A (en) 2000-01-10
UY25580A1 (es) 2001-08-27
EP1089973A4 (en) 2001-12-12
CN1307560A (zh) 2001-08-08
AR018945A1 (es) 2001-12-12
ES2249017T3 (es) 2006-03-16
RU2211832C2 (ru) 2003-09-10
TR200003859T2 (tr) 2001-07-23
DE69928257D1 (de) 2005-12-15
PL345067A1 (en) 2001-12-03
KR20010053173A (ko) 2001-06-25
ID27137A (id) 2001-03-01
TW548270B (en) 2003-08-21
WO1999067215A1 (en) 1999-12-29
NO20006380D0 (no) 2000-12-14
BR9911373A (pt) 2001-09-18
EP1089973A1 (en) 2001-04-11
ZA200006028B (en) 2002-09-25
IL140414A0 (en) 2002-02-10
JP2002518478A (ja) 2002-06-25
PE20000729A1 (es) 2000-10-28
HUP0104308A2 (hu) 2002-04-29
ATE309211T1 (de) 2005-11-15
HUP0104308A3 (en) 2002-06-28
DE69928257T2 (de) 2006-08-03
AU752320B2 (en) 2002-09-12
EP1089973B1 (en) 2005-11-09
NZ507627A (en) 2003-12-19
CA2336003A1 (en) 1999-12-29
CN1202081C (zh) 2005-05-18

Similar Documents

Publication Publication Date Title
ATE410439T1 (de) Caspase inhibitoren
EP0686642A3 (en) Modified guanidino and amidino thrombin inhibitors
NO20032753L (no) Forbindelse og anvendelse derav
ATE430158T1 (de) Hepatitis c tripeptide inhibitoren
EE200100003A (et) Ekskavaatorite ja teiste sarnaste seadiste hammaste ühendussõlm
IS5302A (is) Nýjar amidínóafleiður og notkun þeirra sem þrombínhemla
PL356066A1 (en) Caspase inhibitors and uses thereof
DK1137635T3 (da) N-substituerede 2-cyanopyrrolidiner
PL348648A1 (en) Cyclic tetrapeptide compound and use thereof
DK1004669T3 (da) Hidtil ukendte differentieringsinhibitor
IS4930A (is) Nýjar amidínóafleiður og notkun þeirra sem þrombínhemla
DE69920428D1 (de) Ansaugleitung
BR9607412A (pt) Inibidor de trombina e composto
DK0958287T3 (da) Sulfamidmetalloprotease-inhibitorer
DE69928257D1 (de) Amidino- und guanidino-azetidinone tryptase-inhibitoren
MA25391A1 (fr) Inhibiteurs d'alcenyl et alcynyl metalloproteases.
DE59911747D1 (de) Sauganlage
IS5990A (is) Nýjar amidínbensýlamínafleiður og notkun þeirra sem þrombínhemlar
NO20003814L (no) Trombininhibitorer
DE69826216D1 (de) Lärmschutz
ATE252547T1 (de) Matrixmetalloproteinaseinhibitoren
DK1135381T3 (da) Eletriptanhydrobromidmonohydrat
DE69733263D1 (de) Markierte elastase-inhibitoren
DK0997644T3 (da) Gerotormotor
ID29383A (id) Perekat yang mengeras dalam beberapa tingkatan

Legal Events

Date Code Title Description
FC2A Withdrawal, rejection or dismissal of laid open patent application